Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: ciprofloxacin / aspirin attending: chief complaint: living unrelated kidney transplant for esrd secondary to calcineurin induced toxicity major surgical or invasive procedure: : living unrelated kidney transplant history of present illness: 32f s/p olt in for budd chiari and subsequently developed budd chiari in her transplanted liver necessitating the need for splenorenal shunt. she now presents with renal insufficiency secondary to calcineurin inhibitors for her olt and will undergo a living unrelated transplant from a friend. she reports feeling well and denies fevers, chills, nausea, vomiting, diarrhea, rhinorrhea, dysuria or brbpr. she does report however some recent fatigue as well a cough which is chronic and believed to be from her ace inhibitor. she was last sick 2 years ago when she developed pneumonia. she has been off her coumadin since sunday. past medical history: diabetes mellitus, hypertension, obesity psh: psh: olt ' c/b budd chiari requiring splenorenal shunt, tubal ligation, appendectomy, exlap social history: does no work, occasional etoh, no smoking, no illicit drugs family history: mother - fibromyalgia, sarcoid father - no contact physical exam: t 98.0 p 82 bp 130/93 rr 18 o2 100ra pe: gen - a&o x 3 cv - rrr pulm - ctab abd - obese, well healed chevron and lower midline incisions, soft, nontender, nondistended ext - no edema pertinent results: on admission: wbc-8.4 rbc-3.71* hgb-11.4* hct-33.9* mcv-91 mch-30.7 mchc-33.6 rdw-13.6 plt ct-297 pt-16.2* ptt-30.3 inr(pt)-1.5* glucose-200* urean-61* creat-3.7* na-138 k-4.9 cl-110* hco3-16* angap-17 alt-29 ast-32 alkphos-200* totbili-0.5 albumin-4.4 calcium-10.0 phos-4.8* mg-2.3 on discharge: wbc-8.4 rbc-3.25* hgb-9.8* hct-29.5* mcv-91 mch-30.0 mchc-33.0 rdw-14.0 plt ct-198 pt-15.9* ptt-46.4* inr(pt)-1.4* glucose-247* urean-24* creat-1.0 na-139 k-4.2 cl-109* hco3-23 angap-11 alt-27 ast-22 alkphos-142* totbili-0.7 calcium-9.1 phos-2.3* mg-1.5* tacrofk-15.0 brief hospital course: 32 y/o female s/p olt with splenorenal shunt, now with renal insufficiency secondary to drug toxicity here for living unrelated kidney transplant. she has been off her coumadin for 3 days and was started on heparin pre-op as a bridge. the patient was taken to the or with dr . routine induction immunosuppression to include atg 125 mg ( for 3 total doses) cellcept and solumedrol with prednisone taper was given. the kidney had to be placed upside down as the renal vein would not reach to the common iliac vein. the donor ureter was anastomosed end-to-side to the native ureter as in the upside position of the kidney, the ureter was unable to reach the bladder. this anastomosis was completed over a 6-french double-j stent. it was noted that the kidney, while making urine on the table, did respond to sbps less than 130 by appearing slightly ischemic on one pole. due to this finding, she was admitted to the sicu post op for maintenance of her bps > 130 with neo. in addition it was felt that the atg may have caused some hypotension, so it was run in slower. she stayed overnight in the icu and was transferred the following day with stable blood pressures, excellent urine output and a creatinine down to 1.0 by day of discharge. liver enzymes took a small bump but were back within normal limits by discharge. she was discharged to home with the jp drain. she was tolerating diet, ambulating without difficulty and pain was well managed. medications on admission: amlodipine 10mg daily, nexium 20mg daily, lantus 22 units qhs, humalog ss, lisinopril 20mg daily, prograf 1mg daily, coumadin 2.5mg daily, oscal 500mg/400units discharge medications: 1. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours) as needed. 2. warfarin 2.5 mg tablet sig: one (1) tablet po once daily at 4 pm. disp:*10 tablet(s)* refills:*1* 3. valganciclovir 450 mg tablet sig: one (1) tablet po daily (daily). 4. tacrolimus 1 mg capsule sig: two (2) capsule po q12h (every 12 hours) for 2 doses. 5. prednisone 5 mg tablet sig: five (5) tablet po once (once) for 1 doses. disp:*5 tablet(s)* refills:*0* 6. bactrim 80-400 mg tablet sig: one (1) tablet po once a day. 7. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po twice a day. 8. nystatin 100,000 unit/ml suspension sig: five (5) ml po four times a day. 9. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po once a day. disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 10. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: one (1) tablet po once a day. 11. insulin glargine 300 unit/3 ml insulin pen sig: eighteen (18) units subcutaneous at bedtime. 12. humalog 100 unit/ml cartridge sig: per sliding scale subcutaneous four times a day. 13. percocet 5-325 mg tablet sig: 1-2 tablets po every four (4) hours as needed for pain. disp:*30 tablet(s)* refills:*0* discharge disposition: home discharge diagnosis: esrd s/p lurt discharge condition: good discharge instructions: please md or visit er if you experience any of the following: temp>101.5, chest pain, shortness of breath, severe abdominal pain, drainage or redness from your incision, severe nausea/vomiting, inability to tolerated food or any other symptom that is concerning to you. do not drive while on pain medication keep incision clean and dry. do not soak in tub however you may shower. please record daily drain outputs. followup instructions: provider: , md phone: date/time: 12:50 provider: , transplant social work date/time: 1:30 provider: , md phone: date/time: 2:40 procedure: other kidney transplantation transplant from live non-related donor diagnoses: end stage renal disease unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified complications of transplanted liver surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other drugs and medicinal substances causing adverse effects in therapeutic use budd-chiari syndrome 

Answer: The patient is high likely exposed to